Outcome and Toxicity Profile of Stereotactic Body Radiation Therapy for Adrenal Tumours in Dogs
Veterinary and Comparative Oncology · 2026
DOI: 10.1111/vco.70035 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Veterinary and Comparative Oncology, 2026. Verfasst von Lily Thorsen und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Small Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, Gainesville, Florida, USA. Hauptthemen laut MEDLINE: Dog Diseases, Radiosurgery, Adrenal Gland Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Stereotactic body radiation therapy (SBRT) has become a non‐invasive alternative option for canine adrenal tumours with high surgical risks; however, its clinical benefits and risks are still to be fully understood. The goal of this multi‐institutional retrospective study was to describe the clinical outcome and safety of SBRT for the treatment of 21 dogs with adrenal tumours. Ten were suspected pheochromocytomas, two adenocarcinomas, and the diagnosis was unknown in nine dogs. Vascular invasion was present in 81% of cases (17/21). Thirteen dogs received 3 fractions of 6 to 11 Gy, 7 received 5 fractions of 6 to 9 Gy, and 1 received 4 fractions of 6 Gy. For the 20 patients with follow‐up imaging, 9 (43%) had partial response, 10 (47%) stable disease, and 1 (5%) progressive disease. Progression‐free survival was 16.8 months (95% CI: 3.4–23), and overall survival time was 16.8 months (95% CI: 3.7–23.7). Twelve patients (57%) experienced acute adverse events (AEs); of those, seven were gastrointestinal grade ≥ III, including one grade V. Late AEs were suspected in seven dogs (33%), including gastrointestinal grade V in four of them. A total of five dogs (24%) died from radiation‐related toxicities. Although SBRT seems to be effective against adrenal tumours, it was associated with a high morbidity and mortality rate, suggesting that re‐evaluation of radiation therapy protocols is necessary for maintaining patient safety.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Small Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, Gainesville, Florida, USA.
- MSPCA-Angell Animal Medical Center, Boston, Massachusetts, USA.
- Department of Veterinary Medicine & Surgery, College of Veterinary Medicine, University of Missouri, Columbia, Missouri, USA.
- Colorado Animal Specialty & Emergency, Boulder, Colorado, USA.
- North Shore Center for Medical Aesthetics, LTD, Northbrook, Illinois, USA.
ORCID-Profile: Jillian Walz, Charles Maitz, Zebulon Thorsen, Marilia Takada
Zitieren
APA
Thorsen, L., Law, K., Walz, J., Coll, V. M., Naramor, A., Maitz, C., Kubicek, L., Thorsen, Z., Gutti, J. R., & Takada, M. (2026). Outcome and Toxicity Profile of Stereotactic Body Radiation Therapy for Adrenal Tumours in Dogs. Veterinary and Comparative Oncology. https://doi.org/10.1111/vco.70035
Vancouver
Thorsen L, Law K, Walz J, Coll VM, Naramor A, Maitz C, et al. Outcome and Toxicity Profile of Stereotactic Body Radiation Therapy for Adrenal Tumours in Dogs. Veterinary and Comparative Oncology. 2026. doi:10.1111/vco.70035
BibTeX
@article{Thorsen2026,
author = {Thorsen, Lily and Law, Kimberley and Walz, Jillian and Coll, Valerie Morales and Naramor, Ada and Maitz, Charles and Kubicek, Lyndsay and Thorsen, Zebulon and Gutti, Jishnu Rao and Takada, Marilia},
title = {Outcome and Toxicity Profile of Stereotactic Body Radiation Therapy for Adrenal Tumours in Dogs},
journal = {Veterinary and Comparative Oncology},
year = {2026},
doi = {10.1111/vco.70035}
}
EUVIMED